Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis

Cancer

Volumn 112, Issue 3, 2008, Pages 544-551

  Wei, Ye Sheng ^a,b   Zheng, Yan Hua ^c   Liang, Wei Bo ^a   Zhang, Jian Zhong ^c   Yang, Zhi Hui ^a   Lv, Mei Li ^a   Jia, Jing ^a   Zhang, Lin ^a,d  

^a SICHUAN UNIVERSITY   (China)

^b YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^c 306 HOSPITAL OF PLA   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Nasopharyngeal carcinoma; Proteomics; Serum biomarkers; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

ADULT; ALGORITHM; ARTICLE; CHINA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 38749100576     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23204     Document Type: Article

References (30)

1. McDermott AL, Dutt SN, Watkinson JC. The aetiology of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci. 2001;26:82-92.
2. Yu MC, Yuan JM. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol. 2002;12:421-429.
3. Sheen TS, Ko JY, Chang YL, et al. Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening. Head Neck. 1998;20:732-738.
4. Chan KH, Gu YL, Ng F, et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer. 2003;105:706-709.
5. Hanash SM. Global profiling of gene expression in cancer using genomics and proteomics. Curr Opin Mol Ther. 2001;3:538-545.
6. Petricoin EF, Zoon KC, Kohn EC, et al. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov. 2002;1:683-695.
7. Verma M, Wright GL Jr, Hanash SM, et al. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers. Ann NY Acad Sci. 2001;945:103-115.
8. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis. 2000;21:1164-1177.
9. Engwegen JY, Gast MC, Schellens JH, et al. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends Pharmacol Sci. 2006;27:251-259.
10. Bouamrani A, Ternier J, Ratel D, et al. Direct-tissue SELDI-TOF mass spectrometry analysis: a new application for clinical proteomics. Clin Chem. 2006;52:2103-2106.
11. Mathelin C, Cromer A, Wendling C, et al. Serum biomarkers for detection of breast cancers: a prospective study. Breast Cancer Res Treat. 2006;96:83-90.
12. Li J, Zhao J, Yu X, et al. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res. 2005;11:8312-8320.
13. Li J, Orlandi R, White CN, et al. Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem. 2005;51:2229-2235.
14. Hu Y Zhang S, Yu J, et al. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. Breast. 2005;14:250-255.
15. Gourin CG, Xia ZS, Han Y, et al. Serum protein profile analysis in patients with head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2006;132:390-397.
16. Soltys SG, Le QT, Shi G, et al. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Clin Cancer Res. 2004;10:4806-4812.
17. Yu Y, Chen S, Wang LS, et al. Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology. 2005;68:79-86.
18. Scarlett CJ, Smith RC, Saxby A, et al. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology. Gastroenterology. 2006;130:1670-1678.
19. Zhu LR, Zhang WY, Yu L, et al. Serum proteomic features for detection of endometrial cancer. Int J Gynecol Cancer. 2006;16:1374-1378.
20. Yang SY, Xiao XY, Zhang WG, et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer. 2005;5:83.
21. Wang JX, Yu JK, Wang L, et al. Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics. 2006;6:5344-5349.
22. Lee AW, Foo W, Law SC, et al. Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system. Int J Cancer. 1999;84:179-187.
23. Scarlett CJ, Saxby AJ, Nielsen A, et al. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture. Hepatology. 2006;44:658-666.
24. Oh JH, Gao J, Nandi A, et al. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling. Genome Inform. 2005;16:195-204.
25. Engwegen JY, Helgason HH, Cats A, et al. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol. 2006;12:1536-1544.
26. He J, Gornbein J, Shen D, et al. Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol. 2007;30:145-154.
27. Tsang RK, Vlantis AC, Ho RW, et al. Sensitivity and specificity of Epstein-Barr virus IgA titer in the diagnosis of nasopharyngeal carcinoma: a 3-year institutional review. Head Neck. 2004;26:598-602.
28. Low WK, Leong JL, Goh YH, et al. Diagnostic value of Epstein-Barr viral serology in nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 2000;123:505-507.
29. Leung SF, Lo YM, Chan AT, et al. Disparity of sensitivities in detection of radiation-naive and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2. Clin Cancer Res. 2003;9:3431-3434.
30. Ho DW, Yang ZF, Wong BY, et al. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma. Cancer. 2006;107:99-107.